Retinal Surgeons News Today

Alimera Sciences, Inc. (NASDAQ:ALIM) Q2 2023 Earnings Call Transcript August 10, 2023 Alimera Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.44 EPS, expectations were $0.06. Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Alimera Sciences Second Quarter 2023 Financial Results Conference Call. [Operator Instructions]. I would […]

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

- Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD announced at ASRS 2022...